Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-30

Clinical Trial Update: Hip Fracture Surgery Timing and Blood Transfusion Risk in Patients on DOACs

View source ↗

Summary

A clinical trial is recruiting to study the timing of hip fracture surgery and the risk of blood transfusion in patients taking direct oral anticoagulants (DOAC…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apixaban (apixaban)
  • Dabigatran (Dabigatran etexilate)
  • Edoxaban (edoxaban)
  • Rivaroxaban (rivaroxaban)

Snippet

Sponsor: St. Antonius Hospital | Conditions: Blood Transfusion, Hip Fracture Surgeries | Status: RECRUITING